Ingredient or product comparison
Snap-8 Peptide: Type Comparison
Snap-8 (Acetyl Octapeptide-3) 8 amino acids SNARE complex competitive inhibition; blocks SNAP-25 binding to syntaxin 130% (30% more potent) ~24 hours 5–10% topical Argireline (Acetyl Hexapeptide-8) 6 amino acids SNARE complex competitive inhibition; mimics SNA
This source-based comparison does not add ratings or recommend a winner.
- Snap-8 (Acetyl Octapeptide-3)
- 8 amino acids
- SNARE complex competitive inhibition; blocks SNAP-25 binding to syntaxin
- 130% (30% more potent)
- ~24 hours
- 5–10% topical
- Argireline (Acetyl Hexapeptide-8)
- 6 amino acids
- SNARE complex competitive inhibition; mimics SNAP-25 N-terminal fragment
- 100% (baseline)
- ~48 hours
- Botulinum Toxin Type A
- 1296 amino acids (full protein)
- Irreversible SNAP-25 cleavage via endopeptidase activity
- 2000–5000% (injected, not topical)
- Months (effect duration)
- 1–4 units per site (injection)
- Leuphasyl (Pentapeptide-18)
- 5 amino acids
- Enkephalin analogue; modulates acetylcholine receptor sensitivity
- 60–80%
- ~36 hours
- 3–5% topical
- Snap-8 peptide occupies a middle ground between Argireline's moderate potency and botulinum toxin's irreversible effect. Offering enhanced inhibition over Argireline without requiring injection or permanent protein modification. For research protocols studying dose-response curves, reversible neuromuscular modulation, or repeated-application kinetics, Snap-8 peptide provides experimental flexibility that botulinum toxin cannot match.